Results 191 to 200 of about 29,210 (297)

Real-world treatment patterns of Bruton tyrosine kinase inhibitors in mantle cell lymphoma in a community oncology setting. [PDF]

Future Oncol
Shah BD, Xue M, Furnback W, Yang K.
europepmc   +1 more source

Effects of ibrutinib treatment on murine platelet function during inflammation and in primary hemostasis

, 2016
Robert H. Lee, Raymond Piatt, Pamela B. Conley, Wolfgang Bergmeier   +3 more
openalex   +1 more source

Near-tetraploidy is associated with Richter transformation in chronic lymphocytic leukemia patients receiving ibrutinib [PDF]

, 2017
Cecelia Miller, Amy S. Ruppert, Nyla A. Heerema, Kami J. Maddocks, Jadwiga Labanowska, H Breidenbach, Gerard Lozanski, Weiqiang Zhao, Amber Gordon, Jeffrey A. Jones, Joseph M. Flynn, Samantha Jaglowski, Leslie A. Andritsos, Kristie A. Blum, Farrukh T. Awan, Kerry A. Rogers, Michael R. Grever, Amy J. Johnson, Lynne V. Abruzzo, Erin Hertlein, James S. Blachly, Jennifer A. Woyach, John C. Byrd   +22 more
openalex   +1 more source

Zanubrutinib in the treatment of Waldenström Macroglobulinemia. [PDF]

Future Oncol
Goodall E, Opat S.
europepmc   +1 more source

INTEGRATED ANALYSIS: OUTCOMES OF IBRUTINIB‐TREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LEUKEMIA (CLL/SLL) WITH HIGH‐RISK PROGNOSTIC FACTORS [PDF]

, 2017
Thomas J. Kipps, Graeme Fraser, Steven Coutré, Jennifer R. Brown, Jacqueline C. Barrientos, Paul M. Barr, John C. Byrd, Susan O’Brien, M.S. Dilhuydy, Peter Hillmen, Ulrich Jaeger, Carol Moreno, Paula Cramer, Stephan Stilgenbauer, A.A. Chanan‐Khan, Michelle Mahler, Mariya Salman, Minghua Cheng, Anil Londhe, Joi Ninomoto, Angela Howes, Danelle F. James, Michael Hallek   +22 more
openalex   +1 more source

Ibrutinib therapy for lymphoplasmacytic lymphoma [PDF]

American Journal of Hematology, 2017
Margaret J. Helber, Jeremiah E. Moore, AnnaLynn M. Williams, Philip J. Meacham, Paul G. Rothberg, Clive S. Zent   +5 more
openaire   +3 more sources

Issue Information

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 10, Page 1527-1530, October 2025.
wiley   +1 more source

The Combination of Ibrutinib with BH3 Mimetics or Dichloroacetate Is Effective in B-CLL. [PDF]

Cells
Marco-Brualla J, Gonzalo O, Azaceta G, Izquierdo I, Palomera L, Villalba M, Marzo I, Anel A.   +7 more
europepmc   +1 more source

Comparative Efficacy of Ibrutinib Versus Obinutuzumab + Chlorambucil in First-Line Treatment of Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison [PDF]

, 2017
Suzy Van Sanden, Simona Baculea, Joris Diels, Sarah Côté   +3 more
openalex   +1 more source

<i>Aspergillus</i> Endocarditis: A Rare but Serious Complication During Treatment With Ibrutinib. [PDF]

Case Rep Infect Dis
Mezzadri L, Caramma IGC, Sciabica IM, Migliorino GM, Cavallero A, Marchetto G, Lapadula G, Bonfanti P.   +7 more
europepmc   +1 more source